Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

ElliottwaveForecast Aug. 11 at 6:32 AM

$JNJ should continue rally targeting 271.37 or higher within daily bull run against May-2026 low. Short term pullback against 6.22.2026 low should remain supported to continue rally to extend ((5)). Check out the details at https://elliottwave-forecast.com/stock-market/jnj-elliott-wave-bullish-rally-targets-271-37-beyond/ #Elliottwave #JNJ

0 · Reply

SniperAlphaCom Aug. 11 at 3:01 AM

$JNJ trade lifecycle update. TS Update #1 was shared with Elite members on June 25, followed by TS Update #2 on July 28. Price respected the updated trailing-stop area near $245, absorbed the pullback, and has now recovered to $261.81. The position remains active. This is why the stop follows structure—not every short-term fluctuation.

0 · Reply

OnlyFibs Aug. 11 at 2:19 AM

Johnson & Johnson $JNJ (2h) Bullish Flow: Institutional flow is slamming the Ask across long-dated leaps, including a massive $114.5K split sweep on January 2027 $290 Calls and $35.1K in August $272.50 Calls. Smart money is aggressively accumulating after $JNJ hit the $100.8B full-year revenue milestone while locking in a comprehensive $5.5B talc settlement to remove the primary legal overhang off the balance sheet. 🐂 💧 Bull Key Level: $262.50 (Bull confirmation to break the horizontal consolidation ceiling and launch a macro blue-sky continuation run) 🐂 🔥 Bear Key Level: $252.00 (Key structural support floor and ascending trendline anchor to defend) 🐻 ⚠️ Targets: $275.00 / $290.00 💰 🍺

0 · Reply

LiveTradePro Aug. 10 at 11:02 PM

$JNJ Good volume at the close Looks ready https://share.trendspider.com/chart/JNJ/6682nu5lwf

0 · Reply

focafoca99 Aug. 10 at 10:56 PM

$JNJ set to appear at Morgan Stanley's 24th Annual Global Healthcare Conference on Sep 14, with a fireside chat at 11:30 a.m. ET. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-participate-8c316e

0 · Reply

TheUnmaker Aug. 10 at 8:18 PM

$TNXP Today confirmed the setup with massive over than average volume. Algos re ready to run higher. We will break $14.15 this week and then looking for demand over $16. $PFE $JNJ $GRAL $SLS

1 · Reply

tonyp262 Aug. 10 at 8:01 PM

$JNJ nutty pop at the end there! One of the few pharma’s that have steered away from vaccines which provides a safe haven for healthcare investors amidst the vaccine decision by the current administration

0 · Reply

MessAndGetHorns Aug. 10 at 7:50 PM

$ESTA Just bought back my shares I trimmed in the upper 80s. Currently holding 500 shares. Breast implants for the win and Motiva is the Queen of the boob job market! $SPY $QQQ $ABBV $JNJ

0 · Reply

Tnitty4371 Aug. 10 at 5:54 PM

$ONFO 🎁🎁🎁💵💵💵🎁🎁💵💵💎😎📈📈$SPY $TSLA $META $JNJ

0 · Reply

Orbit100 Aug. 10 at 4:48 PM

$JNJ Funds rotation from the big boys into bio tech stocks.

0 · Reply

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

2026-08-07T19:33:43.000Z - 3 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now to Get Paid in September — 8/7/26

CVX WMT

Aug 6, 2026, 6:23 PM EDT - 4 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

AMAT AXP COF CRWD GS KLAC LLY

2026-08-06T10:48:29.000Z - 5 days ago

Johnson & Johnson price target raised to $287 from $270 at Guggenheim

2026-08-05T18:48:12.000Z - 5 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks for Dependable Income, 8/5/26

IBM KO

Aug 4, 2026, 4:05 PM EDT - 6 days ago

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

2026-08-04T12:50:51.000Z - 7 days ago

Johnson & Johnson announces Taubert to retire as EVP, Worldwide Chairman

Aug 4, 2026, 8:45 AM EDT - 7 days ago

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

Aug 3, 2026, 8:00 AM EDT - 8 days ago

Johnson & Johnson Transcript: Investor update

2026-08-03T11:00:29.000Z - 8 days ago

Johnson & Johnson price target raised to $282 from $272 at Wells Fargo

2026-08-03T09:35:43.000Z - 8 days ago

Johnson & Johnson removed from US Conviction List at Goldman Sachs

Aug 2, 2026, 8:00 AM EDT - 9 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

2026-07-30T12:35:46.000Z - 12 days ago

Johnson & Johnson’s head & neck cancer candidate granted FDA Priority Review

Jul 30, 2026, 8:30 AM EDT - 12 days ago

Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Jul 29, 2026, 6:13 PM EDT - 12 days ago

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines

Jul 29, 2026, 5:42 PM EDT - 12 days ago

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

2026-07-29T21:40:31.000Z - 12 days ago

Johnson & Johnson sees Firefly, Sail Biomedicines dilute FY27 EPS by $1.36

Jul 29, 2026, 5:38 PM EDT - 12 days ago

Johnson & Johnson lowers 2026 profit forecast

2026-07-29T21:35:31.000Z - 12 days ago

Johnson & Johnson cuts FY26 EPS view to $10.86-$11.01, consensus $11.68

2026-07-29T21:35:19.000Z - 12 days ago

Johnson & Johnson affirms FY26 revenue view of $100.8B-$101.4B

Jul 29, 2026, 5:28 PM EDT - 12 days ago

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

Jul 29, 2026, 12:01 PM EDT - 12 days ago

Explainer: Can J&J finally put the talc litigation behind it?

2026-07-29T13:31:13.000Z - 12 days ago

Johnson & Johnson price target raised to $300 from $290 at Argus

Jul 28, 2026, 4:31 PM EDT - 13 days ago

Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

Jul 28, 2026, 12:26 PM EDT - 13 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 1:03 AM EDT - 14 days ago

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Jul 28, 2026, 12:31 AM EDT - 14 days ago

J&J offers $5.5bn to settle baby powder lawsuits

Jul 27, 2026, 9:29 PM EDT - 14 days ago

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

Jul 27, 2026, 6:47 PM EDT - 14 days ago

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Jul 27, 2026, 6:31 PM EDT - 14 days ago

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

Jul 27, 2026, 5:45 AM EDT - 15 days ago

Robert Kiyosaki sees a brutal depression ahead: 3 stocks that may protect portfolios

NEM WMT

$TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma$

Jul 23, 2026, 8:30 AM EDT - 19 days ago

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

Jul 22, 2026, 4:33 PM EDT - 19 days ago

US judge casts doubt on 69,000 cases alleging J&J talc caused cancer

Jul 22, 2026, 7:21 AM EDT - 20 days ago

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

Jul 22, 2026, 7:00 AM EDT - 20 days ago

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

Jul 21, 2026, 6:30 PM EDT - 20 days ago

Jim Cramer says this old-school investing concept still wins — even in the AI boom

BNY CVS GS MMM WFC

Jul 16, 2026, 8:11 AM EDT - 26 days ago

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award

Jul 16, 2026, 8:00 AM EDT - 26 days ago

DePuy Synthes Acquires Expanding Innovations™

Jul 15, 2026, 12:09 PM EDT - 26 days ago

J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

Jul 15, 2026, 8:30 AM EDT - 27 days ago

Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 27 days ago

Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 27 days ago

Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 27 days ago

Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 7:27 AM EDT - 27 days ago

ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market

ASML INTC

Jul 15, 2026, 6:35 AM EDT - 27 days ago

Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:33 AM EDT - 27 days ago

Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:25 AM EDT - 27 days ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

Jul 15, 2026, 6:23 AM EDT - 27 days ago

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Jul 15, 2026, 6:20 AM EDT - 27 days ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 9, 2026, 1:00 PM EDT - 4 weeks ago

The Big 3: UNH, KO, JNJ

KO UNH

Jul 8, 2026, 7:45 AM EDT - 4 weeks ago

Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jul 6, 2026, 6:29 PM EDT - 5 weeks ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

PEP SBUX STZ TJX

Jun 26, 2026, 2:39 PM EDT - 6 weeks ago

Healthcare stocks have become a haven for investors ditching tech

ABBV ABSI APGE LLY MRNA SNY XBI

Jun 26, 2026, 12:35 PM EDT - 6 weeks ago

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Jun 25, 2026, 5:00 AM EDT - 6 weeks ago

Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Jun 15, 2026, 6:00 AM EDT - 2 months ago

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

$New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:41 AM EDT - 2 months ago

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

$New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:33 AM EDT - 2 months ago

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

Jun 11, 2026, 7:45 AM EDT - 2 months ago

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

Jun 11, 2026, 2:03 AM EDT - 2 months ago

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

Jun 10, 2026, 11:22 AM EDT - 2 months ago

Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial

Jun 10, 2026, 6:20 AM EDT - 2 months ago

Johnson & Johnson CEO Says Cure for Certain Cancers Is Realistic Goal

Jun 9, 2026, 10:00 AM EDT - 2 months ago

Johnson & Johnson Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN LLY MRK NVO PFE

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 8:08 AM EDT - 2 months ago

Johnson & Johnson to buy Firefly Bio for $1 billion

ElliottwaveForecast Aug. 11 at 6:32 AM

0 · Reply

SniperAlphaCom Aug. 11 at 3:01 AM

0 · Reply

OnlyFibs Aug. 11 at 2:19 AM

0 · Reply

LiveTradePro Aug. 10 at 11:02 PM

$JNJ Good volume at the close Looks ready https://share.trendspider.com/chart/JNJ/6682nu5lwf

0 · Reply

focafoca99 Aug. 10 at 10:56 PM

0 · Reply

TheUnmaker Aug. 10 at 8:18 PM

$TNXP Today confirmed the setup with massive over than average volume. Algos re ready to run higher. We will break $14.15 this week and then looking for demand over $16. $PFE $JNJ $GRAL $SLS

1 · Reply

tonyp262 Aug. 10 at 8:01 PM

0 · Reply

MessAndGetHorns Aug. 10 at 7:50 PM

$ESTA Just bought back my shares I trimmed in the upper 80s. Currently holding 500 shares. Breast implants for the win and Motiva is the Queen of the boob job market! $SPY $QQQ $ABBV $JNJ

0 · Reply

Tnitty4371 Aug. 10 at 5:54 PM

$ONFO 🎁🎁🎁💵💵💵🎁🎁💵💵💎😎📈📈$SPY $TSLA $META $JNJ

0 · Reply

Orbit100 Aug. 10 at 4:48 PM

$JNJ Funds rotation from the big boys into bio tech stocks.

0 · Reply

Orbit100 Aug. 10 at 4:47 PM

$JNJ Shorts will wake up in the morning and don't know what hit them.

0 · Reply

Orbit100 Aug. 10 at 4:46 PM

$JNJ Ready to soar this week.

0 · Reply

Tnitty4371 Aug. 10 at 4:25 PM

$SCKT 💵🎁💎💵🎁💎 $SPY $TSLA $META $JNJ being in the right position at the right time will get you rich 😎

0 · Reply

twiggs462 Aug. 10 at 3:20 PM

$JNJ purchased Janssen Pharmaceuticals, eight years after it was originally founded... 2H of 2027 will be eight years since $DFTX was founded... :)

0 · Reply

Matt_1 Aug. 10 at 3:00 PM

$CVRX $GSK $JNJ 😎👍

0 · Reply

theoptionsplug Aug. 10 at 2:59 PM

$JNJ forming a beautiful bull flag on the daily chart Current support sits at $255 which if held, targets at $263 then $270! (50DMA brings an additional layer of support at $250)

0 · Reply

Orbit100 Aug. 10 at 2:44 PM

$JNJ Market is showing a great resilience. S&P is predicted more bigt gains ahead. Shorts are in for a big surprise. Heed the warning or lose a great deal amount of money keeping their positions opened.

0 · Reply

Orbit100 Aug. 10 at 2:42 PM

$JNJ More large gain of the market ahead this month.

0 · Reply

Tnitty4371 Aug. 10 at 2:24 PM

$AAPL 💎💵💎🎁💎💵🎁 $SPY $TSLA $META $JNJ

0 · Reply

TheUnmaker Aug. 10 at 2:08 PM

$TNXP Break $14.15 and we go back over $16 this week. $PFE $SLS $JNJ $GRAL

1 · Reply

La_Parka3 Aug. 10 at 1:50 PM

$MRNA $PFE $JNJ The mandates of pandemic past continue to haunt the shorts as they still use it as their excuse to explain away why vaccines continue to sell when the mandates had been cancelled completely several years ago.

0 · Reply

Orbit100 Aug. 10 at 1:46 PM

$JNJ Baby powder settlement is scheduled only to pay in 2027 in different amounts. Meanwhile this is a very solid company. It is set up to soar this year. Watch and learn.

0 · Reply

Market Cap	624.74B
Revenue (ttm)	94.19B
Net Income (ttm)	26.80B
EPS (ttm)	N/A
PE Ratio	23.66
Forward PE	22.13
Profit Margin	28.46%
Debt to Equity Ratio	0.44

Volume	8,985,100
Avg Vol	8,472,492
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	60%
Beta	0.24
Analysts	Strong Sell
Price Target	$275.42